Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 10:55 PM
Study NCT ID:
NCT06368167
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-04-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-11
First Submit QC Date:
None
Study First Post Date:
2024-04-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-11
Last Update Post Date:
2024-04-16
Last Update Post Date Type:
ACTUAL